4.8 Article

Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 164, Issue 2, Pages 183-186

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2012.02.031

Keywords

Cancer model; Cell culture; Mouse; Xenograft; Preclinical

Funding

  1. NIH/NCI [CA96823, CA112354]

Ask authors/readers for more resources

Experiments with cultures of human tumor cell lines, xenografts of human tumors into immunodeficient mice, and mouse models of human cancer are important tools in the development and testing of anticancer drugs. Tumors are complex structures composed of genetically and phenotypically heterogeneous cancer cells that interact in a reciprocal manner with the stromal microenvironment and the immune system. Modeling the complexity of human cancers in cell culture and in mouse models for preclinical testing is a challenge that has not yet been met although tremendous advances have been made. A combined approach of cell culture and mouse models of human cancer is most likely to predict the efficacy of novel anti-cancer treatments in human clinical trials. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available